Zydus Wellness Board of Directors

Get the latest insights into the leadership at Zydus Wellness. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Sharvil P Patel Chairman
Mr. Tarun G Arora WholeTime Director & CEO
Mr. Ganesh N Nayak Non Executive Director
Mr. Kulin S Lalbhai Independent Director
Mr. Akhil A Monappa Independent Director
Mr. Srivishnu Raju Nandyala Independent Director
Ms. Dharmishtaben N Raval Independent Woman Director

Zydus Wellness Share price

ZYDUSWELL

2423.8

95.40 (4.10%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:50 IST
BUYSELL
Today's High

2454.00

Today's Low

2310.50

52 Week Low

1493.20

52 Week High

2454.00

The current prices are delayed, login to your account for live prices

Zydus Wellness FAQs

The board at Zydus Wellness consists of experienced professionals, including Dr. Sharvil P Patel , Mr. Tarun G Arora , and others, overseeing the company’s strategic and corporate governance.

Directors at Zydus Wellness are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Sharvil P Patel is the current chairman at Zydus Wellness.

Executive directors at Zydus Wellness are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Zydus Wellness adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Zydus Wellness, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.